Catalyst Wire Dossier Catalyst Wire Dossier

Metaglidasen

· Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Metaglidasen, covering 2015-05-01 to 2015-05-01. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin [Phase 2, Phase 3]

See pricing